Tarsus Pharmaceuticals Inc (TARS) — Free Cash Flow Generation Index
Tarsus Pharmaceuticals Inc (TARS) has a Free Cash Flow Generation Index of 0.94x as of June 2026. Free cash flow of $62.70 Million represents 1% of operating cash flow ($66.77 Million). Explore how much does Tarsus Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tarsus Pharmaceuticals Inc Free Cash Flow Generation Index (2021–2021)
Historical FCF Generation Index trend for Tarsus Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see TARS cash flow metrics.
Annual Free Cash Flow Generation for Tarsus Pharmaceuticals Inc (2021–2021)
Year-by-year Free Cash Flow Generation Index for Tarsus Pharmaceuticals Inc. Check TARS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.84x | $3.16 Million | $3.75 Million | $586.00K | — |